Experts reveal what they think is going on with Donald Trump's legs
Experts have said the president's wobbly leg could be the result of a range of conditions from a 'knock knee' to a more ...
studyfinds6h
Breakthrough blood test could transform ALS diagnosis, care
Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
ALS News Today9h
Using NfL biomarker could improve ALS diagnosis, prognosis: Study
Measuring blood levels of NfL, a biomarker of nerve damage, could help diagnose ALS and predict the risk of death for ...
News Medical9h
Stress granules as potential biomarkers for neurodegenerative diseases
Stress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.
DiagnaMed Holdings Corp.: DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions ...
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...
Le Lézard11h
QALSODYtm (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause
Biogen Canada Inc. announced today that Health Canada has issued marketing authorization with conditions (Notice of Compliance ...
QALSODY™ (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause
Biogen Canada Inc. announced today that Health Canada has issued marketing authorization with conditions (Notice of Compliance with Conditions (NOC/c)) for QALSODY™ (tofersen injection) for the ...